Dunhill Financial’s Astrana Health ASTH Stock Holding History

Dunhill Financial’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56	Hold	1	–	–	﹤0.01%	1500
2026 Q1	$29	Hold	1	–	–	﹤0.01%	1715
2025 Q4	$30	Buy	+1	New	+$27	﹤0.01%	1823

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dunhill Financial's ASTH Position: Q2 2026 in Review

Dunhill Financial held its Astrana Health (ASTH) position steady in Q2 2026 at 1 share worth $56. The position accounts for ﹤0.01% of the portfolio, ranked #1500.

Dunhill Financial first reported a position in ASTH in Q4 2025 and has held it in 3 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

Dunhill Financial held 1 share of Astrana Health worth $56 as of Q2 2026.
Dunhill Financial left its Astrana Health share count unchanged in Q2 2026.
Astrana Health made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #1500 holding.
Dunhill Financial first reported a position in Astrana Health in Q4 2025 and has held it in 3 quarters since.
209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.